E. Rand Sutherland is Chief Executive Officer of Upstream Bio, Inc. (UPB). The company reported total compensation of $4,302,100 for fiscal year 2025.
| Salary | $650,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $3,300,350 |
| Non-equity incentive plan | $341,250 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $10,500 |
| Total | $4,302,100 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Upstream Bio, Inc. filed April 16, 2026, accession 0001193125-26-158966.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $650,000 | $0 | $0 | $3,300,350 | $341,250 | $0 | $10,500 | $4,302,100 |
| FY2024 | Chief Executive Officer | $407,955 | — | — | $8,375,648 | $315,000 | — | $10,350 | $9,108,953 |
Totals as disclosed in each year's own compensation disclosure for Upstream Bio, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| E. Rand Sutherland this page | Chief Executive Officer | $4,302,100 |
| Michael Paul Gray | Chief Financial Officer and Chief Operating Officer | $1,993,437 |
| Aaron Deykin | Chief Medical Officer and Head of Research and Development | $1,830,916 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Upstream Bio, Inc. compensation brief.
E. Rand Sutherland's compensation sits inside Upstream Bio, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.